Activation of AMPK in Human Placental Explants Impairs Mitochondrial Function and Cellular Metabolism

Effect of Maternal Obesity on Placental Lipid Metabolism

(2017) Virtu Calabuig-Navarro et al.   ENDOCRINOLOGY

Effect of ω-3 supplementation on placental lipid metabolism in overweight and obese women

(2016) Virtu Calabuig-Navarro et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The influence of placental metabolism on fatty acid transfer to the fetus

(2016) Simone Perazzolo et al.   JOURNAL OF LIPID RESEARCH

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases

(2015) Beshay N.M. Zordoky et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment

(2015) Giulio Maria Pasinetti et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?

(2015) Marlies de Ligt et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes

(2015) Morten Møller Poulsen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The molecular targets of resveratrol

(2015) Sameer S. Kulkarni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The pharmacology of resveratrol in animals and humans

(2015) Eun-Jung Park et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Neuroprotective action of resveratrol

(2015) Stéphane Bastianetto et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Resveratrol and cancer: Challenges for clinical translation

(2015) Chandra K. Singh et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Activation of AMPK improves inflammation and insulin resistance in adipose tissue and skeletal muscle from pregnant women

(2015) Stella Liong et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Activation of AMPK in human fetal membranes alleviates infection-induced expression of pro-inflammatory and pro-labour mediators

(2015) R. Lim et al.   PLACENTA

Influence of high fat diet and resveratrol supplementation on placental fatty acid uptake in the Japanese macaque

(2015) P. O'Tierney-Ginn et al.   PLACENTA

Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates

(2014) Victoria H. J. Roberts et al.   FASEB JOURNAL

Maternal obesity is associated with a lipotoxic placental environment

(2014) J. Saben et al.   PLACENTA

Glucose and Fatty Acid Metabolism in Placental Explants From Pregnancies Complicated With Gestational Diabetes Mellitus

(2014) Francisco Visiedo et al.   Reproductive Sciences

Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice

(2014) Bin Wang et al.   Food & Function

High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta

(2013) Francisco Visiedo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice

(2013) Vernon W. Dolinsky et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Resveratrol Improves Adipose Insulin Signaling and Reduces the Inflammatory Response in Adipose Tissue of Rhesus Monkeys on High-Fat, High-Sugar Diet

(2013) Yolanda Jimenez-Gomez et al.   Cell Metabolism

Placental oleic acid uptake is lower in male offspring of obese women

(2013) E. Brass et al.   PLACENTA

SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function

(2012) Nathan L. Price et al.   Cell Metabolism

High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

(2012) M. M. Poulsen et al.   DIABETES

Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia

(2012) S.L. Bourque et al.   PLACENTA

Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta

(2011) Melissa J. Cudmore et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats

(2011) Kuan-Hsing Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Safety of resveratrol with examples for high purity, trans-resveratrol, resVida≫

(2011) J. A. Edwards et al.   Annals of the New York Academy of Sciences

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients

(2010) K. R. Patel et al.   CANCER RESEARCH

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

(2009) Bei B. Zhang et al.   Cell Metabolism

AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol

(2009) J.-H. Um et al.   DIABETES

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY